Melinda L. Tursky

Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos

Kaye L. Stenvers, Melinda L. Tursky, Kenneth W. Harder et al. · Molecular and Cellular Biology · 2003 · 248 citations · Full text

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Ashwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck et al. · Cell Reports · 2017 · 123 citations · Full text

Non-responder Hpc Quiescence, Mixed-phenotype Acute Leukemia, Genetics +19

<i>Ex vivo</i>expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line

Abhilasha Tiwari, Melinda L. Tursky, Dolly Mushahary et al. · Journal of Tissue Engineering and Regenerative Medicine · 2012 · 39 citations

Tissue Engineering, Engineering, Biomedical Engineering +23

miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia

Thi Thanh Vu, Friedrich Stölzel, Kristy W. Wang et al. · Leukemia · 2020 · 38 citations · Full text

Engineering, Mixed-phenotype Acute Leukemia, Immunology +18

Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells

Melinda L. Tursky, To Ha Loi, Crisbel M. Artuz et al. · Stem Cell Reports · 2020 · 36 citations · Full text